Showing results (121-130 of 233) with videos related to
Sort By:
Pageof 24
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy|March 14, 2014
Comparison of Tc-99m GSA scintigraphy and CT volumetry for evaluation in portal vein embolizationYumiko Kono, Shuji Kariya, Atsushi Komemushi, et al.Journal of Hepato-Biliary-Pancreatic Sciences|June 27, 2013
Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomyMinako Nagai, Masayuki Sho, Sohei Satoi, et al.Annals of Gastroenterological Surgery|February 3, 2021
Multicenter randomized phase II trial of prophylactic right-half dissection of superior mesenteric artery nerve plexus in pancreatoduodenectomy for pancreatic head cancerSuguru Yamada, Sohei Satoi, Hideki Takami, et al.Histopathology|December 6, 2018
Clinicopathological and immunological features of follicular pancreatitis - a distinct disease entity characterised by Th17 activationHironori Ryota, Mitsuaki Ishida, Sohei Satoi, et al.Cancer Science|February 21, 2007
Immunological evaluation of personalized peptide vaccination with gemcitabine for pancreatic cancerHiroaki Yanagimoto, Takashi Mine, Koutaro Yamamoto, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|March 28, 2021
Does direct invasion of peripancreatic lymph nodes impact survival in patients with pancreatic ductal adenocarcinoma? A retrospective dual-center studyDaisuke Hashimoto, Sohei Satoi, Mitsuaki Ishida, et al.Annals of Surgery|January 7, 2017
Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal MetastasisSohei Satoi, Tsutomu Fujii, Hiroaki Yanagimoto, et al.Annals of Surgery|April 16, 2025
Neoadjuvant Chemotherapy with Gemcitabine and S-1 versus Upfront Surgery for Resectable Pancreatic Cancer: Results of the Randomized Phase II/III Prep-02/JSAP05 TrialMichiaki Unno, Fuyuhiko Motoi, Yutaka Matsuyama, et al.World Journal of Surgery|June 17, 2017
Retrospective Study of the Correlation Between Pathological Tumor Size and Survival After Curative Resection of T3 Pancreatic Adenocarcinoma: Proposal for Reclassification of the Tumor Extending Beyond the Pancreas Based on Tumor SizeMasanao Kurata, Goro Honda, Yoshiaki Murakami, et al.Journal of Hepato-Biliary-Pancreatic Sciences|June 14, 2014
Improved survival with combined gemcitabine and S-1 for locally advanced pancreatic cancer: pooled analysis of three randomized studiesHiroaki Yanagimoto, Hiroshi Ishii, Yousuke Nakai, et al.Pageof 24